Holen Sie sich die Stockscreener-App
41.51
2.42%
0.98
Handel nachbörslich:
41.70
0.19
+0.46%
Crispr Therapeutics Ag-Aktien (CRSP) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
| Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-01-21 | $42.44 | $40.90 | $1.54 | 1,799,800.0 | +2.42% |
| 2025-01-17 | $41.55 | $40.45 | $1.10 | 1,352,930.0 | +0.57% |
| 2025-01-16 | $40.68 | $39.44 | $1.24 | 1,580,246.0 | +3.23% |
| 2025-01-15 | $40.99 | $38.89 | $2.10 | 1,721,996.0 | +1.77% |
| 2025-01-14 | $40.20 | $38.21 | $1.99 | 1,474,445.0 | -1.26% |
| 2025-01-13 | $39.20 | $36.52 | $2.68 | 2,732,657.0 | -2.12% |
| 2025-01-10 | $40.37 | $38.51 | $1.86 | 2,351,279.0 | -3.88% |
| 2025-01-08 | $41.73 | $40.55 | $1.18 | 959,682.0 | -1.50% |
| 2025-01-07 | $44.12 | $41.66 | $2.47 | 1,503,545.0 | -1.20% |
| 2025-01-06 | $44.28 | $41.21 | $3.07 | 2,345,101.0 | +3.44% |
| 2025-01-03 | $42.09 | $40.70 | $1.39 | 1,439,113.0 | -0.99% |
| 2025-01-02 | $41.44 | $39.34 | $2.10 | 1,641,020.0 | +5.26% |
| 2024-12-31 | $39.69 | $38.75 | $0.94 | 1,639,843.0 | +1.84% |
| 2024-12-30 | $39.67 | $38.20 | $1.47 | 2,031,963.0 | -3.42% |
| 2024-12-27 | $41.14 | $39.85 | $1.29 | 1,638,855.0 | -2.56% |
| 2024-12-26 | $41.34 | $40.00 | $1.34 | 1,143,084.0 | +0.32% |
| 2024-12-24 | $41.02 | $39.80 | $1.22 | 759,869.0 | +1.14% |
Crispr Therapeutics Ag-Aktien (CRSP) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Crispr Therapeutics Ag-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der CRSP-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Crispr Therapeutics Ag-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Crispr Therapeutics Ag-Aktien (CRSP) Preisverlauf 2025
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-01 | $44.28 | $36.52 | $7.76 | 22,701,614.0 | +5.46% |
Crispr Therapeutics Ag-Aktien (CRSP) Preisverlauf 2024
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2024-12 | $55.50 | $38.20 | $17.30 | 37,972,028.0 | -24.47% |
| 2024-11 | $59.07 | $45.51 | $13.56 | 37,947,539.0 | +10.30% |
| 2024-10 | $50.50 | $44.44 | $6.06 | 24,303,896.0 | -1.26% |
| 2024-09 | $51.99 | $43.42 | $8.57 | 20,824,992.0 | -1.55% |
| 2024-08 | $57.68 | $44.80 | $12.88 | 26,234,267.0 | -16.70% |
| 2024-07 | $63.68 | $52.31 | $11.37 | 27,485,444.0 | +6.07% |
| 2024-06 | $67.88 | $53.33 | $14.55 | 27,238,287.0 | +0.50% |
| 2024-05 | $59.18 | $51.02 | $8.16 | 28,279,258.0 | +1.42% |
| 2024-04 | $68.39 | $52.73 | $15.66 | 28,384,562.0 | -22.26% |
| 2024-03 | $87.08 | $67.52 | $19.56 | 26,994,065.0 | -19.07% |
| 2024-02 | $91.10 | $62.08 | $29.02 | 50,897,445.0 | +33.79% |
| 2024-01 | $68.48 | $58.29 | $10.19 | 41,804,981.0 | +0.56% |
Crispr Therapeutics Ag-Aktien (CRSP) Preisverlauf 2023
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2023-12 | $76.97 | $55.21 | $21.76 | 74,838,505.0 | -6.19% |
| 2023-11 | $76.19 | $39.76 | $36.43 | 66,955,429.0 | +71.41% |
| 2023-10 | $45.55 | $37.55 | $8.00 | 29,826,181.0 | -14.23% |
| 2023-09 | $51.92 | $44.53 | $7.39 | 16,458,787.0 | -9.24% |
| 2023-08 | $56.95 | $46.05 | $10.90 | 24,217,921.0 | -12.77% |
| 2023-07 | $59.67 | $53.20 | $6.47 | 18,278,881.0 | +2.12% |
| 2023-06 | $68.26 | $55.01 | $13.25 | 26,428,538.0 | -12.34% |
| 2023-05 | $72.00 | $47.60 | $24.40 | 33,718,391.0 | +30.85% |
| 2023-04 | $55.36 | $43.10 | $12.26 | 25,775,755.0 | +8.20% |
| 2023-03 | $51.56 | $42.00 | $9.56 | 21,869,631.0 | -8.29% |
| 2023-02 | $58.50 | $46.52 | $11.98 | 23,321,932.0 | -3.33% |
| 2023-01 | $54.18 | $39.88 | $14.30 | 21,037,836.0 | +25.51% |
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):